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ABSTRACT
EXAMINING THE CO-INFECTION EFFECTS OF HELMINTHS AND
MALARIA IN AN INDONESIAN COMMUNITY
MAY 2021
ANDREA C. RODRÍGUEZ-SÁNCHEZ, B.S., UNIVERSITY OF OKLAHOMA
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Dr. Youssef Oulhote

Malaria is one of the most prevalent vector-borne infectious diseases with major
morbidity and mortality in sub-Saharan Africa and Southeast Asia. Recent
epidemiological studies have shown that co-occurrence of soil-transmitted helminth
(STH) infections, or infection caused by parasitic worms, are associated with increased
risk of malaria infection. However, studies of the association between STH and malaria,
and the effect of antihelminth (deworming) treatments that are more commonly used in
areas with high STH infection rates, are sparse. Therefore, we explored the relationship
between STH and malaria infection in an Indonesian community (N=1997) with high
prevalence of both STH and malaria while controlling for covariates and evaluating the
role of deworming treatment as a covariate. Participants with STH infection and/or
malaria infection were categorized as either infected or uninfected using PCR testing
(cycle threshold count) at both baseline and end of study. Self-report, blood, and stool
samples were used to assess overall STH and malaria infection from September 2008 to
July 2010. Descriptive statistics were used to assess the impact of STH infection on
malaria outcomes. To quantify these associations, robust Poisson regression models were

iv

used to assess the impact of baseline infections including STH infection on malaria while
adjusting for age, sex, and the use of deworming treatment. Approximately 39.5% and
19.1% of all participants were infected with Plasmodium vivax and P. falciparum,
respectively, at the start, while 18.0% and 9.96%, respectively, were infected at the end.
A positive association was observed between Ascaris lumbricoides and P. vivax, and
between Necator americanus and P. falciparum (PR = 1.04, 95% CI = 0.53 to 2.04; PR =
2.07, 95% CI = 1.00 to 4.29, respectively). While a negative association was observed
between N. americanus and P. vivax, and between A. lumbricoides and P. falciparum (PR
= 0.91, 95% CI = 0.44 to 1.89; PR = 0.66, 95% CI = 0.27 to 1.65, respectively). Overall,
two of these models were significant (p = 0.062; p = 0.008; p = 0.030; p = 0.062,
respectively). Similarly, there was a positive association observed between the use of
albendazole treatment and STH and malaria outcomes.
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CHAPTER I
BACKGROUND AND SIGNIFICANCE

A. Introduction
Malaria is considered one of the most severe public health problems in the world,
despite various prevention interventions and recommendations from health professionals
on the benefits of using insecticide-treated bednets (ITNs), early diagnosis and treatment,
and controlling the vectors.1 In 2019, the World Health Organization (WHO) reported
that almost half of the world’s population lives in high risk areas for malaria with an
estimated 229 million clinical episodes and 409,000 deaths attributable to malaria
infections and its complications.2 Although the majority of cases are found in the African
region, in 2019 the WHO reported an estimated 6.3 million cases in the South-East Asia
region and approximately 9000 deaths.2 Overall, an estimated 3.4 billion people in 92
countries are at risk of being infected and developing the disease.3 Due to an efficient
vector transmission, an ideal environment, scarce health resources and socioeconomic
instability, malaria is an especially prevalent disease in young children, pregnant women,
due to incomplete immunity, and travelers.4
In vulnerable populations, malaria is associated with a variety of symptoms that
can range from absent/mild to life threatening disease depending on the blood stage of the
parasite. In an uncomplicated infection, the disease may presents itself in three main
stages, although rarely observed: a cold stage, a hot stage, and a sweating stage with
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symptoms such as fever, chills, headaches, vomiting, and general malaise occurring every
second or third day.5 In contrast, in a more severe infection, symptoms may include organ
failure, severe anemia, acute respiratory distress syndrome, and abnormalities in blood
coagulation.4
These incidence rates can increase depending on region, average environmental
temperature, vector reproduction, and medical access. Individuals who reside in warmer
areas with humid climates that have high population of Anopheles mosquitos (the vector
for malaria), are at higher risk of becoming infected with malaria.6 Additionally, if the
mosquitos are able to live longer and infect more people, then those within that region are
also at higher risk. Other modifiable risk factors include having access to medical
attention and preventative tools such as insecticide-treated bednets and indoor insecticide
treatments (IRS). Without these preventative strategies, the risk of being infected
increases and not getting immediate medical attention increases the likelihood of death
due to malaria infection.6 Therefore, the ability to access these resources over time is a
useful predictor of health risk.
Malaria, however, is not the only vector-borne disease that is common in specific
regions and climates. Soil-transmitted helminths (STH) are parasitic worms that favor
similar conditions to malaria and its vector, and are found in some of the most popular
malaria infected spots such as Sub-Saharan Africa and Southeast Asia.7 Similarly to
malaria cases, more than 1.5 billion people have been infected with STH worldwide, with
over 500 million of those infected being school-age children.7 More specifically,
according to the US Center for Disease Control and Prevention department, over an
2

estimated 1.1 billion cases were seen in 2013 within the African and Southeast Asian
regions.8 Due to similar geographic ranges, and impacted populations, several studies
have investigated the relationships between malaria and STH.
Similarly, to malaria, STH infections are associated with immunocompromising
symptoms that can range from mild to life-threatening depending on infection intensity,
(the number of parasitic worms present in an individual). In a more intense infection, the
most common symptoms that are present are diarrhea, abdominal pain, nutrient
deficiency, general weakness, and impaired growth and physical development.7 In
extreme cases, an infection of very high intensity could present symptoms like intestinal
obstruction, requiring special surgical procedures to resolve.7 With significant infection
prevalence in communities, and with similar risk factors, this study therefore proposes a
secondary analysis of data from a randomized control trial (RCT) to examine the
relationship between STH, measured by PCR-based cycle threshold count (Ct) and
malaria infection, as indicated by Ct of parasitemia, among a cohort of Indonesian
household members using data collected between September 2008 and July 2010.

B. Physiology of the Relationship between STH and Malaria Infection
Malaria and STH are caused by two different groups of parasites, a Plasmodium
spp. microorganism and either hookworm species or Ascaris species parasitic worms,
respectively.9–11 In general, both parasites require a human host in order to continue their
life cycle, however, the way in which they do so is fairly different. In terms of malaria,
Plasmodium spp. require transportation from a vector, more specifically a female

3

Anopheles mosquito, to penetrate into a human host’s liver through the blood, and then
later on, to the bloodstream.7 Once inside the host, Plasmodium parasites are able to
multiply and prepare for the next transmission to occur through a different Anopheles
mosquito. In contrast, in terms of STH, helminths do not require a vector but do require a
human host and access to feces. The eggs of the helminths are fertilized in feces that later
are deposited on soil which allows the eggs to hatch larvae.10,11 Once in the larval stage,
humans must come into contact with the helminths either through the touch of the
infected soil or through ingestion of larvae in order to become infected.10,11 Once
infected, and depending on the specific helminth, the human host begins to show
symptoms and increase parasitic density. Although these parasites have very different life
cycles and transmissions, these two infections may impact the host’s immune system in a
similar way, lowering the host’s defenses and reproducing at a fast rate causing major
clinical impacts. In addition, it has been found that STH infections causes an immune
response in the host that suppresses T-cell activity, or a body’s ability to respond to
infection quickly, and renders the host more susceptible to other co-infections.12
Due to such an impactful effect of infection, and the fact that co-infections are
common, it has been hypothesized that when one infection occurs, the human host may
be more susceptible to another infection at the same time or later in life due to an
impaired ability to react to subsequent infection.13 As a result, communities are
attempting to keep up with these co-infections by providing specific treatments that
mainly target the controllable infection such as STH and are readily accessible. 7,14 These
types of treatments are called antihelminth treatments, with albendazole being the most
common. By providing a treatment that focuses on reducing the density and burden of
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STH, it may influence how the host is able to fight off the remaining malaria infection,
impacting the host’s chances of better clinical outcomes from a co-infection.

C. Epidemiology of the Relationship between STH and Malaria Infection
Five epidemiologic studies have evaluated the co-infection between STH and
malaria, all of which are cross-sectional in design.15–19 Of these studies, two studies took
place in West Africa (Ghana, and Nigeria),16,17 two in Central Africa (Gabon and
Cameroon),15,19 and one in Ethiopia.18 Age ranges were 0-15 years in two studies,15,19 0100 years in one study,16 0-40 years in one study,17 and 15-45 years in one study.18 In all
the studies, information was collected via questionnaires, along with both blood samples
(both thick and thin sample slides) and stool samples,15–19 In terms of the outcome, all the
studies evaluated helminth and malaria as a co-infection, while three studies also looked
at helminth and malaria infection individually.15,16,18 Overall, all the studies included age,
sex, and socioeconomic status as covariates.14-18 Three studies found a positive
association between helminth and odds of malaria infection,17–19 one study was null,16
and one found an inverse association.15 In terms of a possible confounding, only two
studies considered deworming treatment having an effect on infection,16,19 with one
finding evidence for a positive association.19
In the only study that yielded a positive association when considering a
deworming treatment, Ndamukong-Nyanga et al. conducted a cross-sectional survey that
involved 1138 school-aged children in Southwest Cameroon.19 Participants consisted of
children of both sexes between the ages of 4 and 15 years who had been enrolled in one
of the study schools that had received parental/guardian consent between 2012 and 2014.
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Questionnaires, fever assessment, blood, and stool samples were collected from eligible
participants. Additionally, all individuals that were positive for either malaria or STH
infection received free malarial and deworming treatments as part of a community
prevention program. Overall prevalence for individual malaria and helminth infection
was 38% and 2.5% respectively, however, prevalence for co-infection was significantly
lower ranging from 2.6% to 0.2% depending on the location of the schools.
In summary, all five epidemiological studies were limited in regard to study
design and sample size, all with a cross-sectional design and only two studies with a
sample size larger than 1000 people,16,19 and all of the studies were conducted in Africa.
Out of the two studies taking into consideration deworming treatment, neither of which
assessed it as a covariate, rather just focused on the infections overall.
D. Study Objectives, Significance and Innovation
This study proposes to assess the relationship between STH infection, and risk of
malaria, both measured by disease infection in Indonesian communities adjusting for age,
sex, and use of deworming treatment. Specifically, the aim of the study is:

Specific Aim: Use data collected from household surveys in Indonesian
villages to evaluate the relationship between STH infection and risk of
malaria.

Hypothesis 1: People with a positive STH infection will have a higher risk
for malaria co-infection, as compared to people who are negative for STH
infection.
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This investigation will contribute to the sparse epidemiological literature on the
association between STH and malaria infection among Indonesian communities.
This proposal is innovative in being one of the few to study the relationship
between STH infection and risk of malaria infection in Indonesia as opposed to SubSaharan Africa, focusing on helminth co-infection affecting risk of malaria. It is also
innovative in its power to control for covariates and ability to evaluate the role of
albendazole treatment as a covariate.
This study is significant because co-infection rates and the use of deworming
treatments are rapidly growing in places like Africa and Southeast Asia. Few studies have
looked at the association between STH and malaria infection among Southeast Asian
regions, and this study can contribute to a more comprehensive understanding of this
relationship and its risk factors.
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CHAPTER II
STUDY DESIGN AND METHODS

A. Study Design and Population
We evaluated the relationship between STH and malaria infection in Indonesian
communities using data from the Resource Competition study: an ecological study
conducted between September 2008 and July 2010.13 Adult and children community
members were randomly enrolled from Indonesian village households and were all
initially considered as potential participants for this study. Household members were
eligible to participate if they were adult males, females and children. These households
were located within the Ende district of Flores Island, Indonesia with a focus on
communities within Nangapanda. This particular area was chosen by the investigators
due to a high prevalence for malaria and being a high endemic area for STH.20 All
individuals within a household were considered eligible. The exclusion criteria were: 1)
pregnant women, 2) children younger than 2 years of age, and 3) persons with illness.14
This left 3,491 individuals out of 4,650 eligible for this study. Of these 3,491 participants
included in the dataset, 1,494 participants were excluded due to missing data. This
resulted in a final analytic population of 1,997 participants.
Clinical and demographic data, stool samples for STH infection and blood
samples for malaria infection analyses were collected from the enrolled household
participants at baseline, at 9 months, and at 21 months follow-ups.
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Ethics: This secondary analysis used data collected with approvals by the Ethical
Committee of the Medical Faculty, University of Indonesia approved the overall study
protocol after institutional review (ethical clearance ref; 194/PT02.FK/Etik/2006), with
fully informed written consent from participants or from parents/guardians of children.14

B. Exposure Assessment
Overall STH infection status was obtained using a questionnaire at baseline and
two years after the treatment. Stool samples were collected every year during the study
period from participants in order to obtain STH infection cycle threshold count (Ct). For
the purpose of this analysis, two dichotomous categorical variables were created using Ct
for both Necator americanus and Ascaris lumbricoides, as these are the most common
STH species found in this region of Indonesia. These variables were categorized as either
“uninfected” or “infected” by taking into account that the lower the Ct detected, the
higher the infection density within the individual. Any samples that failed to amplify by
50 Ct were automatically considered uninfected and those that were amplified below 50
Ct were considered infected.13
STH infection status was cross-checked with the information obtained from
puskesmas (government-administered community health clinics) and a research team in
Jakarta at the Department of Parasitology, University of Indonesia.14 Additionally,
specific helminth DNA was extracted from feces and analyzed using validated laboratory
protocol and each sample was tested using real-time Polymerase Chain Reaction (PCR)
to obtain accurate readings from the samples collected and a proper Ct. This specific test
9

was chosen to determine standard measures because PCR is the most accurate method of
determining parasitic density as it correlates with visual fecal egg counts, which is a more
traditional way of detecting and counting soil-transmitted helminths.13

C. Outcome Assessment
To obtain information on malaria status, the same questionnaire mentioned above
was used. Follow-up questionnaires regarding general health and malaria related health
concerns were given to each household every month. The survey questions assessed
respondents had medically diagnosed malaria or if they show any malaria related
symptoms. In this case, malaria symptoms are defined as fever (oral temperature greater
than 37.5°C) and/or history of fever within 48 hours. In addition to malaria infection
status, infection density was also obtained by collecting peripheral blood samples on
randomly selected individuals over four years of age within each household at baseline,
12 months, and 24 months follow-up. Additionally, to properly assess the whole study
population, those that were not chosen for venous blood collection had their finger
pricked to evaluate malaria status. These samples were used to determine Ct of three
species: Plasmodium falciparum, P. malariae, and P. vivax and used to determine the
overall infection status of an individual. Any samples that failed to amplify by 50 Ct were
considered uninfected.13 For the purpose of this analysis, two dichotomous variables were
created using Ct for both Plasmodium falciparum and P. vivax, as these are the most
common malaria species in the Indonesia. These variables were categorized as either
“uninfected” or “infected”.
10

To assess validity of the malaria Ct, the reported values were cross-checked with
the official community records mentioned above in the assessment of exposure and
through proper laboratory procedures. These procedures consisted of using the blood
samples collected and extracting them for DNA to test against specific polymers using
multiplex PCR. The polymers selected are specifically used to detect some of the main
human-infecting malaria pathogens (P. falciparum, P. vivax, and P. malariae).13
Additionally, blood smears were also assessed using a laboratory protocol Giemsa stain
and examined by expert microscopists.10

D. Covariate Assessment
Risk factors associated with both STH and malaria infection were assessed as
possible confounders. These covariates included: age (in years), sex of individuals (male
or female), and use of deworming treatment at baseline and end of study period.13 They
were abstracted from clinical records and questionnaires administered at baseline and
monthly follow-ups. These were used to control for confounding in the potential
relationship between co-infection of STH and malaria. To use deworming treatment as a
covariate, this variable will be dichotomously categorized as “yes” or “no”.
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CHAPTER III
DATA ANALYSIS
Specific Aim: Use data collected from households in Indonesian villages to evaluate the
relationship between STH infection and risk of malaria.

All statistical analyses were conducted using RStudio version 1.2.5033.
Modification such as creating new variables were made to account for STH and malaria
infection outcome measures and missing data among the covariates. This modified
dataset was only used for multivariable model building.

A. Descriptive Analysis
The total study population and the percent of participants who did not have a STH
or malaria infection, as well as the number and percent of those missing data were
assessed. The total number and percentage of those with STH or malaria infection was
also calculated. The mean and SD of those with and without malaria infection were
calculated for both baseline and end of study period time points.

B. Bivariate Analysis
The prevalence of STH and malaria infections were compared in regard to study
population characteristics chi-square (X2) tests and Fisher’s exact tests for small cell
frequencies. ANOVA was used to obtain p-values for continuous covariates.

C. Multivariable Analysis
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Robust Poisson regression modeling was used to assess the relationship between
STH and malaria infection. Separate models were made for each STH and malaria
pathogen species at both baseline and end of study period. Covariates that caused a 10%
change in the coefficient for STH infection was considered a confounding factor and
included in all the final models. Prevalence ratios and 95% confidence intervals were
reported for unadjusted and adjusted coefficient estimates.
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CHAPTER IV
RESULTS
The final dataset consisted of 1,997 participants, as can be seen in Table 1. Of the
1,997 participants included in this analysis, 789 (39.5%) were infected with N.
americanus at baseline and 359 (18.0%) at the end of follow-up, while 382 (19.1%) were
infected with A. lumbricoides at baseline and 199 (9.96%) at the end of the study period.
The mean age (SD) of participants infected with N. americanus and A. lumbricoides at
baseline was 33.2 (19.3) and 26.5 (18.7) respectively (t-test: p = 0.049 and <0.001), while
the mean age (SD) of participants infected with N. americanus and A. lumbricoides at the
end of follow-up was 35.2 (20.1) and 27.5 (20.1) respectively (t-test for difference: p =
0.0011, and 0.0702 respectively). The proportion of females infected was higher in those
infected with either N. americanus or A. lumbricoides at both baseline and end of study
(58.7%, 42.6%, and 61.3%, 65.3% respectively) as seen in Figure 1, although this
difference was not statistically significant (X2 test: p = 0.629; 0.405; 0.396; and 0.07
respectively). A similar and not statistically significant increase was observed in
participants who were treated with albendazole and were infected with N. americanus
(0% vs 21.2%) or A. lumbricoides (0% vs 22.6%) at the end of the study when compared
to the baseline (X2 test: p = 0.737 and 0.779 respectively).
Results from P. vivax and P. falciparum infections are presented in Tables 2, 3, 4,
and 5. Of the 1,997 participants, 122 (6.11%) were infected with P. vivax at baseline and
40 (2%) at the end of study, while 138 (6.91%) were infected with P. falciparum at
baseline and 39 (1.95%) at the end of study. There was a slight increase in the number of
males (50.8%) that were infected with P. vivax at baseline, with an inverse situation of
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more females (60%) infected at end of study. On the contrary, more females were more
likely to be infected with P. falciparum at both baseline and the end of study (58.7% and
66.7% respectively) as seen in Tables 4 and 5. The mean age (SD) of those infected with
P. vivax at baseline and end of study was 24.1 (16.4) and 24.8 (18.3). Similarly, the mean
age (SD) of those infected with P. falciparum at baseline and end of study was 23.2
(16.5) and 28.8 (18.8) respectively (Tables 2, 3, 4, and 5). In general, the number and
percent of participants between 23 – 33 years of age that were infected with a
Plasmodium spp. was greater at baseline than participants infected at the end of study of
the study. Overall, there was significant increase in participants that received albendazole
treatment and were found to be infected with either P. vivax (0% vs 47.5%) or P.
falciparum (0% vs 53.8%) at the end of study when compared to those infected at
baseline (p = <0.001).
Tables 6 and 7 shows the associations between dichotomized STH infection and
P. vivax and P. falciparum infection. We observed a nonsignificant increase in the coinfection between P. falciparum and N. americanus in an unadjusted model but observed
a significant increase in the adjusted model (PR = 1.13, 95% CI = 0.60 to 2.11, p = 0.711;
PR = 2.07, 95% CI = 1.00 to 4.29, p = 0.01, respectively). Similarly, we also observed a
small nonsignificant increase in P. vivax infection among participants infected with A.
lumbricoides as compared to those not infected in both the unadjusted and adjusted
model (PR = 0.97, 95% CI = 0.49 to 1.93, p = 0.932; PR = 1.04, 95% CI = 0.53 to 2.04, p
= 0.912, respectively). On the contrary, we observed a nonsignificant decrease in P.vivax
infection among participants infected with N. americanus, as well as in P. falciparum
infection among those infected with A. lumbricoides as compared to those not infected in
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both the unadjusted and adjusted models (PR = 0.64, 95% CI = 0.34 to 1.20, p = 0.165;
PR = 0.91, 95% CI = 0.44 to 1.89, p = 0.802; PR = 0.56, 95% CI = 0.25 to 1.26, p =
0.162, respectively). However, in the adjusted model for P. falciparum infection among
those infected with A. lumbricoides, there was a significant decrease observed (PR =
0.66, 95% CI = 0.27 to 1.65, p = 0.030). Furthermore, we observed some non-statistically
significant collinearities between STH and malaria infection at baseline and P. vivax at
the end of study in an adjusted robust Poisson regression model (PR = 0.11, p = 0.8272),
as well as a slightly positive increase in mean age and a decrease in female participants
that were infected with P. vivax when compared to those not infected (PR = 1.00, 95% CI
= 0.97 to 1.02; PR = 0.69, 95% CI = 0.25 to 1.87, respectively), although these
differences were not significant (p = 0.816; p = 0.464).
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CHAPTER V
DISCUSSION
In this secondary analysis of a randomized control trial of STH and malaria coinfection in Indonesia, we observed both positive and negative associations between both
STH infections and malaria parasitemia as measured by PCR. More specifically, we
observed an overall decrease in participants infected with either P. vivax or P. falciparum
at baseline and end of study when compared with those not infected. In other words, as
STH infections were decreasing from baseline to end of study, malaria infections were
also decreasing at those time points. In addition, we observed an increase in females
being infected from baseline to end of study when compared to males being infected.
Although statistical significant effects were not found with sex and were found with coinfection, these results are consistent with previous literature17–19 and suggest potential
for decreased malaria infection among those with STH infection. Interestingly, a positive
association was also observed between the use of albendazole treatment and both STH
and malaria infections, especially between N. americanus and P. falciparum. However,
even though overall STH and malaria infections decreased between baseline and end of
study, we observed an increase in the number of participants with malaria infections at
the end of study that were treated with albendazole compared to the number of
participants with malaria infection at baseline who received albendazole treatment, which
is a similar result that a previous study had observed,16 although only a few
epidemiological studies have assessed the role deworming treatments may have on
immune responses.
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This study is not without limitations. One important limitation is loss to follow-up,
since participant information was obtained from voluntary questionnaires. It is possible
that individuals that developed less severe symptoms or were asymptomatic classified
themselves as not infected with either STH or malaria. These individuals could have been
less concerned about the outcome of the study as they might have seen it as timeconsuming or a burden to participate in. In addition, it is possible that individuals might
have not had the resources to participate for longer periods of time and therefore decide
to leave the study early. This form of differential loss to follow-up would result in an
attenuation of any measure association.
Non-differential misclassification of malaria outcome could have also occurred in
our study, resulting in an underestimation of the association between STH and malaria
infection. Participants were considered uninfected if samples failed to amplify by 50 Ct.
Therefore, if a participant had provided samples during the incubation period, it would
have been missed by the PCR. Since STH infection was also established using the same
cut off Ct, this could have also misclassified participants in our study.
Regardless of the potential limitations, our study has several strengths. The
prospective study design and collection of data at multiple time points limit the potential
for temporal bias or recall bias which are common in other study designs that are used in
previous literature. Our ability to adjust for covariates and evaluate the role of
albendazole treatment as a covariate makes our study unique from other studies that also
evaluated STH and malaria infection. Our study population was also a high-risk, but
under-studied cohort of people in a community in Flores, Indonesia.
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Overall, the present study found that those infected with P. vivax are negatively
associated to those with an initial A. lumbricoides infection but positively associated to
those with an initial N. americanus infection, while individuals infected with P.
falciparum are positively associated to those with an initial N. americanus infection and
negatively associated to those with an initial A. lumbricoides infection. Therefore,
depending on the specific malaria infection, individuals can be more at risk of coinfection than those without an initial STH infection. This study provides preliminary
results that lay the foundation for future studies assessing the association between STH
and malaria infection among Indonesian communities. Further studies evaluating
albendazole treatment as either an effect modifier or potential exposure to co-infection
are warranted and will help explain the impact of co-infection has on communities at high
risk such as Indonesia.
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Table 1. Number and percent in final sample; n=1997
Total
Percent
10,473
100%

Original Study Sample

Excluded

Pregnant women,
children younger than
2 years, ill persons

3,491

33.33%

Missing Data

1,494

14.26%

1,997

19.07%

Final Sample Size
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Figure 1. Malaria infection by sex
P.vivax/P.fal @ baseline = Plasmodium vivax/Plasmodium falciparum
infection status at baseline; P.vivax/P.fal @ end = Plasmodium
vivax/Plasmodium falciparum infection status at end of study.
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Table 2. Distribution of covariates according to Plasmodium vivax infection at baseline
Malaria Status
uninfected
(N=1875)

infected
(N=122)

Total
(N=1997)

Sex
Male
Female

750 (40.0%)
1125 (60.0%)

62 (50.8%)
60 (49.2%)

812 (40.7%)
1185 (59.3%)

0.01853

Age (in years)
Mean (SD)
Median [Min,
Max]

32.6 (19.8)
33.4 [4.10,
80.1]

24.1 (16.4)
17.5 [4.16,
69.1]

32.1 (19.7)
32.7 [4.10,
80.1

<0.0001

1439 (76.7%)
436 (23.3%)

122 (100%)
0 (0%)

1561 (78.2%)
436 (21.8%)

<0.0001

p-value

Albendazole
Treatment
No
Yes

22

Table 3. Distribution of covariates according to Plasmodium vivax infection at end of
study
Malaria Status

Sex
Male
Female
Age (in years)
Mean (SD)
Median [Min,
Max]

uninfected
(N=1957)

infected
(N=40)

Total
(N=1997)

796 (40.7%)
1161 (59.3%)

16 (40.0%)
24 (60.0%)

812 (40.7%)
1185 (59.3%)

0.9315

32.2 (19.8)
32.9 [4.10,
80.1]

24.8 (18.3)
16.3 [5.16,
61.4]

32.1 (19.7)
32.7 [4.10,
80.1]

0.0106

1540 (78.7%)
417 (21.3%)

21 (52.5%)
19 (47.5%)

1561 (78.2%)
436 (21.8%)

<0.0001

p-value

Albendazole
Treatment
No
Yes

23

Table 4. Distribution of covariates according to Plasmodium falciparum infection
at baseline
Malaria Status
uninfected
(N=1859)

infected
(N=138)

Total
(N=1997)

Sex
Male
Female

755 (40.6%)
1104 (59.4%)

57 (41.3%)
81 (58.7%)

812 (40.7%)
1185 (59.3%)

Age (in years)
Mean (SD)
Median [Min,
Max]

32.7 (19.8)
33.8 [4.10,
80.1]

23.2 (16.5)
16.7 [4.23,
72.4]

32.1 (19.7)
32.7 [4.10,
80.1]

<0.0001

1423 (76.5%)
436 (23.5%)

138 (100%)
0 (0%)

1561 (78.2%)
436 (21.8%)

<0.0001

p-value
0.8733

Albendazole
Treatment
No
Yes
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Table 5. Distribution of covariates according to Plasmodium falciparum infection at
end of study
Malaria Status

Sex
Male
Female
Age (in years)
Mean (SD)
Median [Min,
Max]

uninfected
(N=1958)

infected
(N=39)

Total
(N=1997)

799 (40.8%)
1159 (59.2%)

13 (33.3%)
26 (66.7%)

812 (40.7%)
1185 (59.3%)

0.347

32.1 (19.8)

28.8 (18.8)
25.9 [8.12,
69.1]

32.1 (19.7)
32.7 [4.10,
80.1]

0.2677

18 (46.2%)
21 (53.8%)

1561 (78.2%)
436 (21.8%)

<0.0001

32.9 [4.10, 80.1]

p-value

Albendazole
Treatment
No
Yes

1543 (78.8%)
415 (21.2%)
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Table 6. Multivariable association between baseline STH infection and
Plasmodium vivax infection outcome
PR
N. americanus
Uninfected
Infected

0.64

Unadjusted
95% CI
Referent
(0.34, 1.20)

A. lumbricoides
Uninfected

PR
0.91

Adjusted
95% CI
Referent
(0.44, 1.89)

Referent
Referent
0.97
(0.49, 1.93)
1.04
(0.53, 2.04)
Infected
Adjusted for age, sex, and deworming treatment. *p<0.05, **p<0.01
STH = Soil-Transmitted Helminths
The variable for soil-transmitted helminth infection was observed at baseline and the
variable for Plasmodium vivax infection was observed at end of study
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Table 7. Multivariate association between baseline STH infection and
Plasmodium falciparum infection outcome
PR

Unadjusted
95% CI

PR

Adjusted
95% CI

N. americanus
Uninfected
Infected

1.13

Referent
(0.60, 2.11)

2.07

Referent
(1.00, 4.29)**

A. lumbricoides
Uninfected
Infected

0.56

Referent
(0.25, 1.26)

0.66

Referent
(0.27, 1.65)*

Adjusted for age, sex, and deworming treatment. *p<0.05, **p<0.01
STH = Soil-Transmitted Helminths
The variable for soil-transmitted helminth infection was observed at baseline and the
variable for Plasmodium vivax infection was observed at end of study
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